ENTRY       D02074                      Drug
NAME        Amphetamine sulfate (USP);
            Benzedrine (TN);
            Evekeo (TN)
PRODUCT     EVEKEO ODT (Azurity Pharmaceuticals)
  GENERIC   AMPHETAMINE SULFATE (Amneal Pharmaceuticals NY LLC)
            AMPHETAMINE SULFATE (Ascend Laboratories)
            AMPHETAMINE SULFATE (Aurolife Pharma)
            AMPHETAMINE SULFATE (Bionpharma)
            AMPHETAMINE SULFATE (Bryant Ranch Prepack)
            AMPHETAMINE SULFATE (Bryant Ranch Prepack)
            AMPHETAMINE SULFATE (Bryant Ranch Prepack)
            AMPHETAMINE SULFATE (Bryant Ranch Prepack)
            AMPHETAMINE SULFATE (Bryant Ranch Prepack)
            AMPHETAMINE SULFATE (Bryant Ranch Prepack)
            AMPHETAMINE SULFATE (Bryant Ranch Prepack)
            AMPHETAMINE SULFATE (DR. REDDY'S LABORATORIES)
            AMPHETAMINE SULFATE (Epic Pharma LLC)
            AMPHETAMINE SULFATE (Granules Pharmaceuticals)
            AMPHETAMINE SULFATE (Lannett Company)
            AMPHETAMINE SULFATE (Solco Healthcare US)
            AMPHETAMINE SULFATE (SpecGx LLC)
            AMPHETAMINE SULFATE (Sun Pharmaceutical Industries)
            AMPHETAMINE SULFATE (Wilshire Pharmaceuticals)
            EVEKEO (Arbor Pharmaceuticals)
FORMULA     (C9H13N)2. H2SO4
EXACT_MASS  368.177
MOL_WEIGHT  368.4909
CLASS       Metabolizing enzyme substrate
             DG01644  CYP2D6 substrate
REMARK      ATC code: N06BA01
            Chemical structure group: DG00966
            Product (DG00966): D07445<US> D02074<US>
            Product (mixture): D11624<US>
EFFICACY    Stimulant (central)
  DISEASE   Narcolepsy [DS:H01293]
            Attention deficit disorder with hyperactivity [DS:H01895]
TARGET      SLC18A2 (VMAT2) [HSA:6571] [KO:K08155]
            SLC6A2 (NAT1) [HSA:6530] [KO:K05035]
            SLC6A3 (DAT1) [HSA:6531] [KO:K05036]
  PATHWAY   hsa04721(6530+6531+6571)  Synaptic vesicle cycle
            hsa04728(6531+6571)  Dopaminergic synapse
            hsa05031(6531+6571)  Amphetamine addiction
METABOLISM  Enzyme: CYP2D6 [HSA:1565]
INTERACTION  
STR_MAP     map07234  Neurotransmitter transporter inhibitors
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             N NERVOUS SYSTEM
              N06 PSYCHOANALEPTICS
               N06B PSYCHOSTIMULANTS, AGENTS USED FOR ADHD AND NOOTROPICS
                N06BA Centrally acting sympathomimetics
                 N06BA01 Amfetamine
                  D02074  Amphetamine sulfate (USP) &lt;US&gt;
            USP drug classification [BR:br08302]
             Central Nervous System Agents
              Attention Deficit Hyperactivity Disorder Agents, Amphetamines
               Amphetamine
                D02074  Amphetamine sulfate (USP)
            Drug groups [BR:br08330]
             Metabolizing enzyme substrate
              DG01644  CYP2D6 substrate
               DG00966  Amfetamine
                D02074  Amphetamine sulfate
            Target-based classification of drugs [BR:br08310]
             Transporters
              Solute carrier family
               SLC6
                SLC6A2 (NAT1)
                 D02074  Amphetamine sulfate (USP) &lt;US&gt;
                SLC6A3 (DAT1)
                 D02074  Amphetamine sulfate (USP) &lt;US&gt;
               SLC18
                SLC18A2 (VMAT2)
                 D02074  Amphetamine sulfate (USP) &lt;US&gt;
            Drug metabolizing enzymes and transporters [br08309.html]
             Drug metabolizing enzymes
              D02074
            Drug groups [BR:br08330]
             Metabolizing enzyme substrate
              DG01644  CYP2D6 substrate
               DG00966  Amfetamine
DBLINKS     CAS: 60-13-9
            PubChem: 7849136
            ChEBI: 51063
            LigandBox: D02074
            NIKKAJI: J281.197I
ATOM        25
            1   C8y C    21.4900  -16.1000
            2   C8x C    20.3000  -15.4000
            3   C8x C    21.4900  -17.5000
            4   C1b C    22.6800  -15.4000
            5   C8x C    19.0400  -16.1000
            6   C8x C    20.3000  -18.2000
            7   C1c C    23.9400  -16.1000
            8   C8x C    19.0400  -17.5000
            9   C1a C    25.1300  -15.4000
            10  N1a N    23.9400  -17.5000
            11  S4a S    30.3800  -16.6600
            12  O1d O    30.3800  -15.2600
            13  O1d O    30.3800  -18.0600
            14  O1d O    31.7800  -16.6600
            15  O1d O    28.9800  -16.6600
            16  C8y C    21.4900  -16.1000
            17  C8x C    20.3000  -15.4000
            18  C8x C    19.0400  -16.1000
            19  C8x C    19.0400  -17.5000
            20  C8x C    20.3000  -18.2000
            21  C8x C    21.4900  -17.5000
            22  C1b C    22.6800  -15.4000
            23  C1c C    23.9400  -16.1000
            24  C1a C    25.1300  -15.4000
            25  N1a N    23.9400  -17.5000
BOND        24
            1    11  12 2
            2    11  13 2
            3    11  14 1
            4    11  15 1
            5     1   2 2
            6     1   3 1
            7     1   4 1
            8     2   5 1
            9     3   6 2
            10    4   7 1
            11    5   8 2
            12    7   9 1
            13    7  10 1
            14    6   8 1
            15   16  17 2
            16   16  21 1
            17   16  22 1
            18   17  18 1
            19   21  20 2
            20   22  23 1
            21   18  19 2
            22   23  24 1
            23   23  25 1
            24   20  19 1
BRACKET     1    18.4800  -19.2500   18.4800  -14.3500
            1    26.6700  -14.3500   26.6700  -19.2500
            1  2
  ORIGINAL  1    1   2   5   8   6   3   4   7   9  10
  REPEAT    1   16  17  18  19  20  21  22  23  24  25
///
